Prediction of preterm birth

Minerva Ginecologica

Volumn 65, Issue 3, 2013, Pages 345-360

  Borg, F ^a   Gravino, G ^a   Schembri Wismayer, P ^a   Calleja Agius, J ^a,b  

^a UNIVERSITY OF MALTA   (Malta)

^b MATER DEI HOSPITAL   (Malta)

Author keywords

Biological markers; Cytokines; Polymorphism, genetic; Premature birth

Indexed keywords

ARSENIC; CAFFEINE; CHLORPHENOTANE; CORTICOTROPIN RELEASING FACTOR; DRINKING WATER; ESTRIOL; FETAL FIBRONECTIN; FIBRONECTIN; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NITRATE; RELAXIN; SOMATOMEDIN C; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABORTION; AIR POLLUTION; ALCOHOL ABUSE; BODY MASS; BODY WEIGHT; COCAINE DEPENDENCE; DISEASE ASSOCIATION; ECHOGRAPHY; HIGH RISK POPULATION; HISPANIC; HUMAN; INTRAUTERINE GROWTH RETARDATION; LABOR ONSET; MATERNAL AGE; MATERNAL NUTRITION; MATERNAL SMOKING; MATERNAL STRESS; MEDICAL HISTORY; MENTAL DISEASE; NEGRO; OPIATE ADDICTION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREMATURITY; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE WOMAN; SOCIAL STATUS; SUBSTANCE ABUSE; THIRD TRIMESTER PREGNANCY; UTERINE CERVIX INCOMPETENCE; UTERUS CONTRACTION; WATER CONTAMINATION; WORK;

BIOLOGICAL MARKERS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; PREGNANCY; PREMATURE BIRTH; RISK FACTORS;

EID: 84882425209     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Mercer BM, Goldenberg RL, Das A, Moawad AH, Lams JD, Meis PH et al. The preterm prediction study: A clinical risk assessment system. Am. J. Obstet. Gynecol. 1996;174(6):1885-95.
2. Norman J, Greer I. Preterm Labour: Managing Risk in Clinical Practice. UK: Cambridge University Press; 2005.
3. Lockwood CJ, Senyei E, Dische MR, Casal D, Shah KD, Thung SN et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325:669-74.
4. Leitich H, Kaider A. Fetal fibronectin - how useful is it in the prediction of preterm birth? BJOG. 2003;110 Suppl 20:66-70
5. McKenna DS, Chung K, Lams JD. Effect of digital cervical examination on the expression of fetal fibronectin. J Reprod Med 1999;44:796-800.
6. Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ 2002;325:301-4.
7. Chandraharan E, Arulkumaran S. Recent advances in management of preterm labor. J Obstet Gynecol India 2005;55:118-24.
8. Leitich H, Brumbauer M, Kaider A, Egarter C, Husslein P. Cervical length and dilation of the internal os detected by vaginal ultrasonography as markers for preterm delivery: A systematic review. Am J Obstet Gynecol 1999;181:1465-72.
9. Yost NP, Bloom SL, Twickler DM, Leveno KJ. Pitfalls in ultrasonic cervical length measurement for predicting preterm birth. Obstet Gynecol 1999, 93:510-6.
10. Guzman ER, Walters C, Ananth CV, O'Reilly-Green C, Benito CW, Palermo A et al. A comparison of sonographic cervical parameters in predicting spontaneous preterm birth in high-risk singleton pregnancies. Ultrasound Obstet Gynecol 2001;18:204-10.
11. Garfield RE. Structural and functional studies of the control of myometrial contractility and labour. In: McNellis D, Challis JRG, MacDonald PC, Nathanielsz PW, Roberts JM, editors. The Onset of Labour: Cellular and Integrative Mechanisms. Ithaca, NY: Perinatology Press; 1988. p. 55-80
12. McPheeters ML, Miller WC, Hartmann KE, Savitz DA, Kaufman JS, Garrett JM et al. The epidemiology of threatened preterm labor: a prospective cohort study. Am J Obstet Gynecol 2005;192:1325-9; discussion 1329-30.
13. Lams, JD, Romero R. Preterm birth. In: Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. Philadelphia, PA: Churchill Livingstone Elsevier; 2007. p. 668-712.
14. Newman RB, Campbell BA, Stramm SL. Objective tocodynamometry identifies labor onset earlier than subjective maternal perception. Obstet Gynecol 1990;76:1089-92.
15. U. S. Preventive Services Task Force. Home uterine activity monitoring for preterm labor Policy Statement. JAMA 1993;270:369-70.
16. Lams JD, Newman RB, Thom EA, Goldenberg RL, Mueller-Heubach E, Moawad A et al. Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med 2002;346:250-5.
17. Di WL, Lachelin GC, McGarrigle HH, Thomas NS, Becker DL. Estriol and estradiol increase cell to cell communication and connexin43 protein expression in human myometrium. Mol Hum Reprod 2001;7:671-9.
18. Lachelin GC, McGarrigle HH. A comparison of saliva, plasma unconjugated, and plasma total estriol throughout normal pregnancy. Br J Obstet Gynecol 1984;91:1203-9.
19. McGregor JA, Jackson GM, Lachelin GC, Goodwin TM, Artal R, Hastings C et al. Salivary estriol as risk assessment for preterm labor: a prospective trial. Am J Obstet Gynecol 1995;173:1337-42.
20. Ramsey PS, Andrews WW. Biochemical predictors of preterm labor: fetal fibronectin and salivary estriol. Clin Perinatol 2003;30:701-33.
21. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 2005;3:28.
22. Harville EW, Savitz DA, Dole N, Herring AH, Thorp JM. Stress Questionnaires and Stress Biomarkers during Pregnancy. J Womens Health (Larchmt) 2009;18:1435-33.
23. Latendresse G. The Interaction Between Chronic Stress and Pregnancy: Preterm Birth from A Biobehavioral Perspective. J Midwifery Womens Health 2009;54:8-17.
24. Florio P, Linton EA, Torricelli M, Faldini E, Reis FM, Imperatore A et al. Prediction of preterm delivery based on maternal plasma urocortin. J Clin Endocrinol Metab 2007;92:4734-7.
25. Warren WB, Patrick SL, Goland RS. Elevated maternal plasma corticotrophinreleasing hormone levels in pregnancies complicated by preterm labor. Am. J Obstet Gynecol 1992;166:1198-204.
26. Inder WJ, Prickett TC, Ellis MJ, Hull L, Reid R, Benny PS et al. The utility of plasma CRH as a predictor of preterm delivery. J Clin Endocrinol Metab 2001;86:5706-10.
27. Quagliarello J, Szlachter N, Steinetz BG, Goldsmith LT, Weiss G. Serial relaxin concentrations in human pregnancy. Am J Obstet Gynecol 1979;135:43-4.
28. Petersen LK, Skajaa K, Uldbjerg N. Serum relaxin is a potential marker of preterm labor. Br J Obstet Gynecol 1992;99:292-5.
29. Palejwala S, Stein D, Wojtczuk A, Weiss G, Goldsmith LT. Demonstration of a relaxin receptor and relaxin stimulated tyrosine phosphorylation in human lower uterine segment fibroblasts. Endocrinology 1998;139:1208-12.
30. Bryant-Greenwood GD, Kern A, Yamamoto SY, Sadowsky DW, Novy MJ. Relaxin and the human fetal membranes. Reprod Sci 2007;14(8 Suppl):42-5.
31. Giudice LC, Mark SP, Irwin JC. Paracrine actions of insulin-like growth factors and IGF binding protein-1 in non-pregnant human endometrium and at the decidual-trophoblast interface. J Reprod Immunol 1998;39:133-48.
32. Nuutila M, Hiilesmaa V, Karkkainen T, Ylikorkala O, Rutanen EM. Phosphorylated isoforms of insulinlike growth factor binding protein-1 in the cervix as a predictor of cervical ripeness. Obstet Gynecol 1999, 94:243-9.
33. Martina NA, Kim E, Chitkara U, Wathen NC, Chard T, Giudice LC. Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extrembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. J Clin Endocrinol Metab 1997;82:1894-8.
34. Rutanen EM. Insulin-like growth factors in obstetrics. Curr Opin Obstet Gynecol 2000;12(3):l63-8.
35. Ting HS, Chin PS, Yeo GS, Kwek K. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann Acad Med Singapore 2007;36(6):399-402.
36. Laudanski P, Pierzynski P, Laudanski T. Reductionist and system approaches to study the role of infection in preterm labor and delivery. BMC Pregnancy Childbirth 2007;7(Suppl 1):S9.
37. Romero R, Roslansky P, Oyarzun E, Wan M, Emamian M, Novitsky TJ et al. (1988) Labor and infection. II. Bacterial endotoxin in amniotic fluid and its relationship to the onset of preterm labor. Am J Obstet Gynecol 1988;158(5):1044-9.
38. Neta GI, Von Ehrenstein OS, Goldman LR, Lum K, Sundaram R, Andrews W et al. Umbilical Cord Serum Cytokine Levels and Risks of Small-for-Gestational-Age and Preterm Birth. Am J Epidemiol 2010;171:859-67.
39. Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, Mitchell MD. Cytokines, prostaglandins and parturition-a review. Placenta 2003;24(suppl A):S33-46.
40. Velez DR, Fortunato SJ, Morgan N, Edwards TL, Lombardi SJ, Williams SM et al. Patterns of cytokine profiles differ with pregnancy outcome and ethnicity. Hum Reprod 2008;23:1902-9.
41. Keelan JA, Marvin KW, Sato TA, Coleman M, McCowan LM, Mitchell MD. Cytokine abundance in placental tissues: Evidence of inflammatory activation in gestational membranes with term and preterm parturition. Am J Obstet Gynecol 1999;181:1530-6.
42. Wang X, Hagberg H, Mallard C, Zhu C, Hedtjam M, Tiger CF et al. Disruption of interleukin-18, but not interleukin-1, increases vulnerability to preterm delivery and fetal mortality after intrauterine inflammation. Am J Pathol 2006;169:967-76.
43. Sata F, Toya S, Yamada H, Suzuki K, Saijo Y, Yamazaki A et al. Proinflammatory cytokine polymorphisms and the risk of preterm birth and low birthweight in a Japanese population. Mol Hum Reprod 2009;15:121-30.
44. Puchner K, Iavazzo C, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D et al. Mid-trimester amniotic fluid interleukins (IL-lp, IL-10 and IL-18) as possible predictors of preterm delivery. In Vivo 2011;25:141-8.
45. Wei SQ, Fraser W, Luo ZC. Inflammatory Cytokines and Spontaneous Preterm Birth in Asymptomatic Women: A Systematic Review. Obstet Gynecol 2010;116(2 Pt 1):393-401.
46. Gepfert AR, Goldenberg RL, Andrews WW, Hauth JC, Mercer B, Lams J et al. The Preterm Prediction Study: Association between cervical interleukin 6 concentration and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2001;184:483-8.
47. Murtha AP, Greig PC, Jimmerson CE, Herbert WN. Maternal serum interleukin-6 concentration as a marker for impending preterm delivery. Obstet Gynecol 1998;91:161-4.
48. Goldenberg RL, Andrews WW, Mercer BM, Moawad AH, Meis PJ, Lams JD et al. The preterm prediction study: Granulocyte colony-stimulating factor and spontaneous preterm birth. Am J Obstet Gynecol 2000;182:625-30.
49. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
50. Trautman MS, Collmer D, Edwin SS, White W, Mitchell MD, Dudley DJ. Expression of interleukin-10 in human gestational tissues. J Soc Gynecol Investig 1997;4(5):247-53.
51. Ng PC, Li K, Wong RP, Chui K, Wong E, Li G et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003;88:F209-13.
52. Sorokin Y, Romero R, Mele L, Wapner RJ, Lams JD, Dudley DJ et al. Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth < 32 weeks and adverse neonatal outcomes. Am J Perinatol 2010;27:631-40.
53. McLaren J, Taylor DJ, Bell SC. Prostaglandin E (2) - dependent production of latent matrix metalloproteinase-9 in cultures of human fetal membranes. Mol Hum Reprod 2000;6:1033-40.
54. Cockle JV, Gopichandran N, Walker JJ, Levene MI, Orsi NM. Matrix metalloproteinases and their inhibitors in preterm perinatal complications. Reprod Sci 2007;14:629-45.
55. Tu FF, Goldenberg RL, Tamura T, Drews M, Zucker SJ, Voss HF. Prenatal plasma matrix metalloproteinase-9 levels to predict spontaneous preterm birth. Obstet Gynecol 1998;92:446-9
56. Becher N, Hein M, Danielsen CC, Uldbjerg N. Matrix metalloproteinases in the cervical mucus plug in relation to gestational age, plug compartment, and preterm labor. Reprod Biol Endocrinol 2010;8:113.
57. nd edition. New York: Springer-Verlag Berlin Heidelberg; 2008.
58. Jones EA, Clement-Jones M, James OF, Wilson DI. Differences between human and mouse alpha-fetoprotein expression during early development. J Anat 2001;198(Pt 5):555-9.
59. Mizejewski GJ, MacColl R. Alpha-fetoprotein growth inhibitory peptides: potential leads for cancer therapeutics. Mol Cancer Ther 2003;2:1243-55.
60. Graves JC, Miller KE, Sellers AD. Maternal serum triple analyte screening in pregnancy. Am Fam Physician 2002;65:915-20.
61. Moawad AH, Goldenberg RL, Mercer B, Meis PJ, Lams JD, Das A et al. The Preterm Prediction Study: The value of serum alkaline phosphatase, alphafetoprotein, plasma corticotrophin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth. Am J Obstet Gynecol 2002;186:990-6.
62. Duffy MJ, Crown J. A personalized approach to cancer treatment: how biomarkers can help. Clin Chem 2008;54:1770-9.
63. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990;346:561-4.
64. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995;215:89-97.
65. Di Marzo V, Melck, D, Bisogno T, De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 1998;21:521-8.
66. Habayeb OM, Taylor AH, Evans MD, Cooke MS, Taylor DJ, Bell SC et al. Plasma levels of the endocannabinoid anandamide in women-a potential role in pregnancy maintenance and labor? J Clin Endocrinol Metab 2004;89:5482-7.
67. Karalis K, Goodwin G, Majzoub JA. Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labor. Nat Med 1996;2:556-60.
68. Potdar N, Konje JC. The endocrinological basis of recurrent miscarriages. Curr Opin Obstet Gynecol 2005;17:424-8.
69. Laursen LS, Kjer-Sorensen K, Andersen MH, Oxvig C. Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein-4 and -5. Mol Endocrinol 2007;21:1246-57.
70. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004;191:1446-51.
71. Smith GC, Shah I, Crossley JA, Aitken DA, Pell JP, Nelson SM et al. Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol 2006;107:161-6.
72. She BQ, Chen SC, Lee FK, Cheong ML, Tsai MS. Low maternal serum levels of pregnancy-associated plasma protein-A during the first trimester are associated with subsequent preterm delivery with preterm premature rupture of membranes. Taiwan J Obstet Gynecol 2007;46:242-7.
73. Ferrara N, Gerber HP, Le Couter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-76.
74. Cheung CY. Vascular endothelial growth factor: possible role in fetal development and placental function. J Soc Gynecol Investig 1997;4:169-77.
75. Tchaikovski V, Fellbrich G, Waltenberger J. The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes. Arterioscler Thromb Vasc Biol 2008;28:322-8.
76. Straughen J, Kumar P, Misra VK. The effect of maternal soluble FMS-like tyrosine kinase 1 during pregnancy on risk of preterm delivery. J Matern Fetal Neonatal Med 2012; [Epub ahead of print].
77. Ten Dijke P, Goumans MJ, Pardali E. Endoglin in angiogenesis and vascular diseases. Angiogenesis 2008;11:79-89.
78. Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E. Predictive value of angiogenic factors and uterine artery Doppler for early-versus late-onset preeclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008;31:303-9.
79. Chaiworapongsa T, Romero R, Tarca A, Kusanovic JP, Mittal P, Kim SK et al. A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: Evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study. J Matern Fetal Neonatal Med 2009;22:1122-39.
80. Savasan ZA, Romero R, Chaiworapongsa T, Kusanovic JP, Kim SK, Mazaki-Tovi S et al. Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2010;23:828-41.
81. Farina A, Le Shane ES, Romero R, Gomez R, Chaiworapongsa T, Rizzo N et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2005;193:421-5.
82. Barrett AN, Zimmermann BG, Wang D, Holloway A, Chitty LS. Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield. PLoS One 2011;6:e25202.
83. Boyd HA, Poulsen G, Wohlfahrt J, Murray JC, Feenstra B, Melbye M. Maternal contributions to preterm delivery. Am J Epidemiol 2009;170:1358-64.
84. Mumtaz G, Nassar AH, Mahfoud Z, El-Khamra A, Al-Choueiri N, Adra A et al. Consanguinity: A Risk Factor for Preterm Birth at Less Than 33 Weeks' Gestation Am J Epidemiol 2010;172:1424-30.
85. Myking S, Myhre R, Gjessing HK, Morken NH, Sengpiel V, Williams SM et al. Candidate gene analysis of spontaneous preterm delivery: New insights from re-analysis of a casecontrol study using case-parent triads and control-mother dyads. BMC Med Genet 2011;12:174.
86. Plunkett J, Doniger S, Orabona G, Morgan T, Haataja R, Hallman M et al. An Evolutionary Genomic Approach to Identify Genes Involved in Human Birth Timing PLoS Genet 2011;7:e1001365.
87. Bitner A, Kalinka J. IL-ip, IL-6 promoter, TNF-a promoter and IL-1RA gene polymorphisms and the risk of preterm delivery due to preterm premature rupture of membranes in a population of Polish women. Arch Med Sci 2010;6:552-7.
88. Heinzmann A, Mailaparambil B, Mingirulli N, Krueger M. Association of interleukin-13/-4 and toll-like receptor 10 with preteim births. Neonatology 2009;96:175-81.
89. Ferrell G, Lu M, Stoddard P, Sammel MD, Romero R, Strauss JF 3rd et al. A single nucleotide polymorphism in the promoter of the LOXL1 gene and its relationship to pelvic organ prolapse and preterm premature rupture of membranes. Reprod Sci 2009;16:438-46.
90. Gargano JW, Holzman CB, Senagore PK, Reuss ML, Pathak DR, Friderici KH et al. Polymorphisms in thrombophilia and renin-angiotensin system pathways, preterm delivery, and evidence of placental hemorrhage. Am J Obstet Gynecol 2009;201:317.el-9.
91. Ryckman KK, Morken NH, White MJ, Velez DR, Menon R, Fortunato SJ et al. Maternal and Fetal Genetic Associations of PTGER3 and PON1 with Preterm Birth. PLoS One 2010;5:e9040.
92. Haataja R, Karjalainen MK, Luukkonen A, Teramo K, Puttonen H, Ojaniemi M et al. Mapping a new spontaneous preterm birth susceptibility gene, IGF1R, using linkage, haplotype sharing, and association analysis. PLoS Genet 2011;7:e1001293.
93. Menon R, Yu J, Basanta-Henry P, Brou L, Berga SL, Fortunato SJ et al. Short fetal leukocyte telomere length and preterm prelabor rupture of the membranes. PLoS One 2012;7:e31136.
94. Gracie S, Pennell C, Ekman-Ordeberg G, Lye S, Mc-Manaman J, Williams S et al. An integrated systems biology approach to the study of preterm birth using "-omic" technology - a guideline for research. BMC Pregnancy Childbirth 2011;11:71.
95. Goldenberg RL, Lams JD, Mercer BM, Meis PJ, Moawad AH, Cooper RL et al. The preterm prediction study: The value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am J Public Health 1998, 88 233-8.
96. Lams JD, Goldenberg RL, Mercer BM, Moawad AH, Meis PJ, Das AF et al. The Preterm Prediction Study: Can low-risk women destined for spontaneous preterm birth be identified? Am J Obstet Gynecol 2001;184:652-5.
97. Goldenberg RL, Lams JD, Mercer BM, Meis PJ, Moawad A, Das A et al. The Preterm Prediction Study: Toward a multiple-marker test for spontaneous preterm birth. Am J Obstet Gynecol 2001;185:643-51.
98. Rozenberg P, Goffinet F, Malagrida L, Giudicelli Y, Perdu M, Houssin I et al. Evaluating the risk of preterm delivery: a comparison of fetal fibronectin and transvaginal ultrasonographic measurement of cervical length. Am J Obstet Gynecol 1997;176(1 Pt 1):196-9
99. Senden IP, Owen, P. Comparison of cervical assessment, fetal fibronectin and fetal breathing in the diagnosis of preterm labour. Clin Exp Obstet Gynecol 1996;23:5-9.
100. Hincz P, Wilczynski J, Kozarzewski M, Szaflik K. Two-step test: the combined use of fetal fibronectin and sonographic examination of the uterine cervix for prediction of preterm delivery in symptomatic patients. Acta Obstet Gynecol Scand 2002;81:58-63.